SecBot SecBot
8-K ·Filed Jun 24, 2026

PGEN

PRECIGEN, INC.
NEUTRAL
Impact 3/10
Horizonweeks Processed4mo ago SEC0000950103-26-009441
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

No immediate trading catalyst. The 7M share increase is standard equity compensation runway for a ~$1.9B market cap company. Monitor the next 10-Q for actual share issuance under the plan and any potential dilution impact.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$5.52
T+0 close · Jun 24, 2026 · via day close
Latest settled
+40.94%
T+60 · $7.78
Vs SPY
+37.21%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 25 $5.52entry
  2. T+1 · 5mo ago +6.16%α +6.88% · $5.86
  3. T+5 · 5mo ago −4.89%α −6.45% · $5.25
  4. T+20 · 4mo ago +0.36%α −0.17% · $5.54
  5. T+60 · 8w ago +40.94%α +37.21% · $7.78
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Precigen filed an 8-K reporting the results of its 2026 Annual Meeting of Stockholders held on June 18, 2026. Stockholders approved all proposals, including the election of nine director nominees, ratification of Deloitte & Touche as auditor, a non-binding advisory vote on executive compensation, and an amendment to the 2023 Omnibus Incentive Plan to increase the share reserve by 7 million shares. This is a routine governance filing with no material financial impact.

Key Facts

  • All nine director nominees were elected with strong support (lowest 'For' vote was 153.1M for Vinita Gupta, with 57.9M against).
  • Deloitte & Touche LLP ratified as independent auditor for FY 2026 with 272.8M votes for, 254K against.
  • Non-binding advisory resolution on executive compensation approved with 208.2M for, 2.8M against.
  • Amendment to the 2023 Omnibus Incentive Plan approved, increasing shares available for issuance by 7 million.
  • No departures or appointments of directors or officers were reported; Item 5.02 only covers the plan amendment approval.

Financial Impact

No financial impact. The 7 million share increase under the 2023 Plan is a routine authorization for future equity awards, not an immediate issuance.

dilution

Risk Factors

  • Potential future dilution from equity awards granted under the expanded 2023 Plan.
  • Vinita Gupta's 27% vote against (57.9M shares) may indicate some shareholder dissent, though not material.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
78% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000950103-26-009441
Document: 0000950103-26-009441-index-headers.html0000950103-26-009441
Document: 0000950103-26-009441-index.html0000950103-26-009441
Document: 0000950103-26-009441.txt0000950103-26-009441

Track record

13 reports on PGEN

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +52.17% at T+60 after the May 13, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 4, 202612d ago 8-K Bullish 6/10 Entry $4.22 to $4.66 Now $4.30 +1.90% ▲ +10.43% +7.14% vs SPY
  2. Aug 28, 202611w ago Insider Cluster Neutral 3/10 Entry $6.93 to $6.99 Now $4.30 −37.95% ▲ +0.79% +0.94% vs SPY
  3. Aug 26, 202611w ago 144 Neutral 3/10 Entry $7.19 to $7.14 Now $4.30 −40.19% ▼ −0.70% −0.96% vs SPY
  4. Aug 25, 202611w ago Insider Cluster Bearish 4/10 Entry $7.42 to $7.01 Now $4.30 +42.05% ▲ +5.53% +5.41% vs SPY
  5. Aug 25, 202611w ago Insider Cluster Neutral 2/10 Entry $7.42 to $7.01 Now $4.30 −42.05% ▼ −5.53% −5.41% vs SPY
  6. Aug 7, 202614w ago Insider Cluster Neutral 2/10 Entry $7.00 to $6.55 Now $4.30 −38.57% ▼ −6.43% −6.38% vs SPY
  7. Aug 3, 202615w ago Insider Cluster Neutral 2/10 Entry $6.53 to $6.86 Now $4.30 −34.15% ▲ +5.05% +5.15% vs SPY
  8. Jul 1, 202619w ago Insider Cluster Bearish 5/10 Entry $5.64 to $5.53 Now $4.30 +23.76% ▲ +1.95% +2.88% vs SPY
  9. Jun 24, 202620w ago 8-K Neutral 3/10 Viewing Entry $5.52 to $5.25 Now $4.30 −22.10% ▼ −4.89% −6.45% vs SPY
  10. Jun 1, 202624w ago Insider Cluster Neutral 3/10 Entry $3.86 to $3.71 Now $4.30 +11.40% ▼ −3.89% −0.92% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens in 6h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 24, 2026